APA (7th ed.) Citation

Y, W., J, Z., H, Z., & N, X. The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Wu, Zhu J, Zhang H, and Xia N. The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma. Dove Medical Press.

MLA (9th ed.) Citation

Y, Wu, et al. The Combination of D-TACE-HAIC, Lenvatinib, and PD-1 Inhibitors Shows Significant Clinical Efficacy in Patients with Unresectable Hepatocellular Carcinoma. Dove Medical Press.